Part: 12         Session: 145678910111213141516171819202122         Page 793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860 of 999

that they could be more severe than some of the combinations of drugs that people are given for cancers, but as people know that cancer is going to kill them, and they are not sure that they are going to die of a heart attack, they don't take the drug, or at least it isn't being tried.

What amazes me is that as far as I know no drug company is working on this to try to make a more acceptable version of this drug. Now if I would forget about interferon and go on to something else, I could maybe get a drug company to do something about this, but as I am following the interferon thing as best I can almost from day to day, I haven't got the energy to get into whether this drug could be successfully modified. It means going to meetings, it means finding new people that are very well informed that are using it, and finding all the catches to it, and then getting some drug companies -- more than one to improve it. Now that's a lot of work.

To be a real catalyst.

Yes, to be a real catalyst. It's a lot of work to do that. And I should do it. Somebody should do it. I don't think it's being done.

Was it mentioned at all at this convention down in Houston?

No. It might have been referred to. People were talking about drugs, but they were not saying, well, this